Avive Solutions Secures $22M in Series A Funding

Avive Solutions

Avive Solutions, Inc., a San Francisco, CA-based developer of an intelligent AED and connected response platform for out-of-hospital cardiac arrest (OHCA) emergencies, closed a $22m Series A round of financing.

The round was co-led by Questa Capital, Catalyst Health Ventures and repeat investor Laerdal Million Lives Fund.

The company intends to use the funds to advance a new technology-enabled approach for improving OHCA survival rates. Ryan Drant, founder and managing partner of Questa Capital, and Darshana Zaveri, managing partner of Catalyst Health Ventures, both joined the Avive board in connection with the financing.

Led by Sameer Jafri, co-founder and CEO, Avive is a healthcare technology company that is bringing to market a connected automated external defibrillator (AED), coupled with a software platform to address the massive healthcare problem of out-of-hospital cardiac arrest (OHCA). Its connected hardware and software platform will integrate with the existing public safety and provider ecosystems to create a comprehensive OHCA response solution, with the goal of increasing survival rates from cardiac arrest emergencies.

The platform connects with 911 Emergency Communications Centers (ECCs) through a partnership with RapidSOS, and offers incident data-sharing capabilities to providers in an effort to close data gaps that often exist during a cardiac arrest response. 

As part of its technology deployment plan, the company has developed an innovative program called the 4-Minute City. The program includes strategic placement of Avive’s AEDs throughout a city or county and use of its connected platform coupled with community training. By promoting education about OHCA emergencies and preparing citizens to step up when it matters most to deliver early intervention for cardiac arrest, the company is providing an equitable solution in communities where there are often significant disparities in outcomes based on socioeconomic status, race, age and other factors.